Get the Daily Brief
Latest Biotech News
Pig-to-Human Kidney Transplant Advances Immune Understanding
An international team presented groundbreaking insights into immune responses in pig-to-human kidney xenotransplantation at the European Society for Organ Transplantation (ESOT) Congress 2025. The...
Biotech Integration Cuts Cancer Drug Development by Nearly Three Years
A study by Thermo Fisher Scientific and the Tufts Center for the Study of Drug Development indicates that integrated contract research and manufacturing solutions can shorten oncology drug...
Sustainable Production of Acetaminophen from Plastic Waste
Researchers at the University of Edinburgh have engineered Escherichia coli bacteria to convert polyethylene terephthalate (PET) plastic waste into paracetamol (acetaminophen), as reported in...
FDA Faces Scrutiny on Rare Disease and Duchenne Drug Reviews
Recent investigative reports highlight FDA Commissioner involvement in rejecting KalVista Pharmaceuticals' rare disease drug application and ongoing agency review of Sarepta Therapeutics' Duchenne...
Physical Activity Enhances Motor Function in Parkinson’s Disease
A pilot study published in npj Parkinson’s Disease demonstrates that regular physical activity significantly boosts motor function in patients with Parkinson’s disease. The research suggests...
Long-Term Impact of Early-Life Factors on Adult Lung Health
Recent studies explore lifelong respiratory consequences of very low birth weight (VLBW) and antenatal inflammation. One investigation published in Pediatric Research follows adults born with...
Hospital AI Adoption Requires Operational Overhaul
Industry experts caution that hospitals pursuing AI to address financial pressures must first undertake foundational operational changes. Chartis consultant Prashant Karamchandani emphasizes that...
Calls for Reform in 340B Drug Pricing Program by Employers
Employers advocate reform of the 340B Drug Pricing Program, criticizing the mechanism that allows hospitals to acquire medications at steep discounts and bill insured patients at full prices....
E. coli Turns Plastic Waste Into Common Painkiller
Researchers at the University of Edinburgh have engineered Escherichia coli bacteria to convert polyethylene terephthalate (PET) plastic waste into paracetamol. Combining chemical degradation of...
Thermo Fisher-Tufts Link CDMO and CRO for Faster Cancer Drugs
A white paper by the Tufts Center for the Study of Drug Development, commissioned by Thermo Fisher Scientific, finds that integrating contract development and manufacturing organizations (CDMOs)...
BioCryst Sells European Rights to Rare Disease Drug
BioCryst Pharmaceuticals has divested the European rights to its hereditary angioedema treatment Orladeyo to Italy-based Neopharmed Gentili in a $250 million transaction. The deal marks Neopharmed...
Alphabet-Calico and Mabwell Ink $596M Anti-Aging Antibody Deal
Calico Life Sciences, Alphabet’s longevity-focused biotech, has secured exclusive rights outside China to Mabwell Bioscience's IL-11 targeting monoclonal antibody, 9MW3811, through a deal valued...
FDA Faces Rare Disease Drug Review Challenges
BioCentury reports the FDA is conducting landmark reviews of several rare disease drug approvals, testing its commitment to biomarker-based accelerated approval pathways for orphan drugs....
Study Links Antenatal Inflammation to Later Pulmonary Hypertension
A pivotal study published in Pediatric Research reveals that antenatal inflammation contributes to the development of late pulmonary hypertension in bronchopulmonary dysplasia models. This...
UMass Chan Unveils Mechanism Driving Cilia Development Disorders
Researchers at UMass Chan Medical School have elucidated the role of the TMEM67 protein in ciliopathies, a class of genetic disorders affecting cellular antennae function. Their work, spearheaded...
Parkinson’s Motor Function Boosted by Physical Activity
A pilot study published in npj Parkinson’s Disease indicates that increased physical activity improves motor function in patients suffering from Parkinson’s disease. The findings provide clinical...
Danaher Appoints Stumpe as New Chief Technology Officer
Danaher has named Stumpe, formerly at Tempus and Google, as its new Chief Technology Officer. This strategic hire aims to leverage Stumpe’s extensive tech leadership experience to drive innovation...
New Carbon Economy Consortium Meets to Accelerate Carbon Removal
The New Carbon Economy Consortium (NCEC) gathered at the University of Exeter to coordinate global carbon capture efforts. The consortium focuses on advancing technological, policy, and economic...
FDA Overhauls CAR-T Therapy Regulations to Expand Access
The FDA has removed a safety monitoring requirement imposed on CAR-T cell therapies since their 2017 launch, affirming these treatments can be administered safely without the additional oversight....
Calico Secures $596M Deal for Mabwell’s Anti-Aging Therapeutic
Alphabet’s Calico Life Sciences has entered a licensing agreement with China-based Mabwell Bioscience valued up to $571 million, acquiring rights to a clinical-stage monoclonal antibody targeting...